Evidence map›Paper›PMID 38849547›Full record

ArticleInternational journal of legal medicine2024

Investigating cardiac genetic background in sudden infant death syndrome (SIDS).

Francesca Cazzato, Mònica Coll, Simone Grassi, Anna Fernàndez-Falgueras, Laia Nogué-Navarro, Anna Iglesias, Josep Castellà, Antonio Oliva, Ramon Brugada

Abstract read
In one paragraph

Article in International journal of legal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Sally Clark: Trial and error by Judge and Jury.Forensic science international. Synergy · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesca Cazzato *Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Mònica Coll *Cardiovascular Genetics Centre, University of Girona-IDIBGI, 17190, Salt, Spain.
Simone GrassiDepartment of Health Sciences, Section of Forensic Medical Sciences, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. simone.grassi@unifi.it.ORCID http://orcid.org/0000-0002-2420-6658
Anna Fernàndez-FalguerasCardiology Department, Hospital Universitari Doctor Josep Trueta, 17003, Girona, Spain.
Laia Nogué-NavarroFaculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Vic 08500, Can Baumann, Spain.
Anna IglesiasCardiovascular Genetics Centre, University of Girona-IDIBGI, 17190, Salt, Spain.
Josep CastellàForensic Pathology Service, Institut Medicina Legal Ciències Mèdiques Catalunya, Barcelona, Spain.
Antonio OlivaDepartment of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
Ramon BrugadaCardiovascular Genetics Centre, University of Girona-IDIBGI, 17190, Salt, Spain.

Funding

Università Cattolica del Sacro Cuore 2023Università Cattolica del Sacro Cuore Linea D.3.1.
6 · The paper itself

Abstract

Sudden infant death syndrome (SIDS) is still the leading cause of death for newborns in developed countries. The pathophysiological mechanisms have not been fully clarified, but in some of SIDS cases variants of genes associated with inherited cardiac conditions are found. In this study, an analysis of SCD-related genes was performed to determine the prevalence of rare pathogenic (P) or likely pathogenic (LP) variants that could provide an unambiguous explanation for the fatal event. A cohort of 76 SIDS cases underwent Next-Generation Sequencing (NGS) analysis with a custom panel of SCD-related genes. Rare variants were classified according to the guidelines provided by the American College of Medical Genetics and Genomics (ACMG) and the specifications of the ClinGen association. Post-mortem genetic testing identified 50 (65.8%) carriers of at least one variant in SCD genes. 104 rare genetic variants were found, 65.4% in genes encoding structural proteins. Only 4 out of 76 cases (5.3%) hosted at least a P or LP variant found in genes with structural or structural/arrhythmogenic functions (SLC22A5, SCN5A, MYL3and TTN). 99 variants were classified as of uncertain significance (VUS). The difference in the distribution of variants between gene groups by function was not statistically significant (chi square, p = 0,219). Despite this, most of the variants concerned structural genes that were supposed to have a close interaction with ion channels, thus providing an explanation for the arrhythmic event. Segregation analysis, reclassification of VUS variants and identification of new associated genes could clarify the implications of the current findings.

Indexed as

High-Throughput Nucleotide SequencingNAV1.5 Voltage-Gated Sodium ChannelSudden Infant DeathCell Cycle ProteinsConnectinFemaleGenetic TestingGenetic VariationHumansInfantInfant, NewbornMaleMutationMyosin Heavy ChainsOrganic Anion TransportersTranscription FactorsCell Cycle ProteinsConnectinMyosin Heavy ChainsNAV1.5 Voltage-Gated Sodium ChannelOrganic Anion TransportersSCN5A protein, humanTranscription FactorsTTN protein, humanForensic autopsyPost-mortem genetic testingSudden Cardiac DeathSudden Infant Death Syndrome

Identifiers

PMID38849547
PMCPMC11490465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.